News & press
Partnerships, licensing, publications
For press inquiries write to contact@gordion.bio.
Prof. Sabine Tejpar joins our Scientific Advisory Board
Head of the Laboratory of Molecular Digestive Oncology at KU Leuven, she co-led the Consensus Molecular Subtypes (CMS1–4) of colorectal cancer. Together we are developing new therapeutic strategies for MSS colorectal cancer, where checkpoint immunotherapy has largely failed.
Research collaboration with Biomunex PharmaceuticalsWe will apply network analysis and computational target discovery to identify bispecific target combinations for Biomunex's BiXAb® platform.
Keynote at Cancer Cures, The Heart, WarsawCEO Pawel Zawadzki on why experimental systems miss human tumor complexity, and what patient-level data changes in therapy design.
MTAP program licensed to Kohde PharmaTargets identified through patient-derived dependency mapping, not detectable in standard cell-line models. MTAP deletions occur in ~15% of cancers.